Pay as you go. Fixed prices. No subscriptions
We won’t overcharge you through a subscription model. Our one off economical prices remain fixed all the time
Pay as you go. Fixed prices. No subscriptions
We won’t overcharge you through a subscription model. Our one off economical prices remain fixed all the time
A GLP-1 receptor agonist that helps reducing food noise by reducing appetite, curb cravings and improve blood-sugar control.
In a 68‑week trial, adults taking weight loss treatment alongside lifestyle changes lost on average around 15% of their body weight, significantly more than those on placebo.¹
Start weight management treatment with specialist review and ongoing support.
A medicated weight loss programme for those who are clinically eligible and want to improve their health and their weight-related complications. It is not a shortcut or a first-line solution for weightloss, it is medicated weight management support with weightloss as one of the possible outcomes
Body‑mass criteria:
Weight loss treatment is usually considered for adults with a BMI of over 30 or BMI of 27 with at least one weight related condition such as hypertension, PCOS and etc.
Alongside lifestyle change
Weight loss treatment can be used when lifestyle changes alone have not been efficient enough in managing obesity related conditions.
Structured assessment
Clinical decision‑making
A WeightFall clinician then reviews this information and talks through your goals to decide whether Weight loss treatment fits safely into your medicated weight management plan.
Weight loss treatment will be ruled out in certain situations, including if you:
In clinical studies, WeightFall patients lost more weight, in less time.¹
Your BMI Results:
You share your health and medication history.
A clinician will check your answers and submitted photos.
We confirm if weight loss treatment is appropriate for you.
Check‑ins every 3 weeks to review side effects, see how your current weight loss treatment dose feels, and decide whether to maintain, adjusting treatment.
Weight loss treatment is a prescription-only weight loss injection used as part of a medicated weight management programme for adults living with obesity or overweight and related health conditions.
It contains Semaglutide, which acts on gut hormone receptors involved in appetite and blood‑sugar control. It is used alongside diet and physical‑activity changes and is only considered where clinically appropriate.
Any decision to start or continue treatment is made by a qualified prescriber after medical review.
Weight loss treatment is used as part of medicated weight management for adults who meet specific criteria.
It contains semaglutide, which acts like a natural gut hormone involved in appetite, cravings, and healthy weight management decisions.
Reduces appetite:
Weight loss treatment acts on areas of the brain that regulate hunger, helping you feel fuller sooner and reducing the urge to overeat.
Curbs cravings:
Protects the heart:
Proven results:
In large clinical trials, people taking it lost up to 20.7% of their body weight over 72 weeks, far more than lifestyle changes alone.
It is only one part of weight management; your clinician will review wahether it remains the right option for you alongside lifestyle changes and ongoing monitoring in a medicated weight management plan.
Weight loss injection is one of the most widely studied prescription treatments for adults living with overweight or obesity. When used alongside healthy changes to eating and activity, research shows it can help many people achieve meaningful weight loss.
In clinical studies, around 86% of people lost at least 5% of their body weight, and about half lost 15% or more ¹ when using it as part of a structured weight-management plan. Other specialist clinic data also suggests that people taking semaglutide at obesity treatment doses lost around 6% of their weight within three months, increasing to around 11% by six months. ²
Longer-term research indicates that weight loss with semaglutide can be maintained over time, with many people continuing to keep weight off compared with those not using treatment. Alongside weight reduction, some people also experience improvements in waist size and health markers linked to excess weight.
Everyone responds differently. Some people notice steady changes over time, while others may see more modest results. Your clinician will review your progress regularly and will only recommend continuing treatment if it is providing meaningful benefit for you.
Why Choose
Focused, clinician-led weight management service to support you long term and not just a quick fix. Our clinical team consists of clinicians specialised in GLP-1 treatments and are experienced in building you a tailored weight management plan.
Specialist coaching supports your lifestyle changes, so it is one part of a broader and healthy weight management plan.
UK‑registered clinicians are available to review and monitor your progress, adjust Weight loss treatment doses and answer medical questions.
Your Weight loss treatment is delivered to your chosen UK address in secure, discreet packaging.
Our structured pathways for Weight loss treatment for the UK are built on clinical guidance and experience with many patients.
It’s more than just weight loss.
Dosage
Pricing
Review
Status
0.25mg
£85
Every 3 weeks
Starting dose
0.5mg
£85
Every 3 weeks
Titration dose
1mg
£90
Every 3 weeks
Possible maintenance dose
1.7mg
£139
Every 3 weeks
Possible maintenance dose
Feature
Weight loss injection (semaglutide)
GLP‑1 (tirzepatide)
Dosage range
Typically increased from 0.25 mg up to 2.4 mg once weekly, following a step‑up schedule.
Typically increased from 2.5 mg up to 15 mg once weekly, following a structured titration schedule.
How often you take it
Once a week, on the same day each week.
Once a week, on the same day each week.
How long you can take it
Licensed for long‑term use for weight management under ongoing medical supervision.
Licensed for long‑term use for weight management under ongoing medical supervision.
How it works
GLP‑1 receptor agonist that curbs appetite, slows stomach emptying and supports blood‑sugar control to help reduce calorie intake.
Dual GIP and GLP‑1 receptor agonist ("twincretin") that suppresses appetite, reduces cravings and improves blood‑sugar control, with a stronger effect on metabolic pathways.
Administration
Once‑weekly self‑injectable pen used into the fatty layer under the skin (abdomen, thigh or upper arm).
Once‑weekly self‑injectable pen used into the fatty layer under the skin (abdomen, thigh or upper arm).
Price range at WeightFall
From £85 per month for Weight loss treatment.
From £149 per month for GLP‑1.
Suitable for
Adults who meet Weight loss treatment eligibility criteria (for example certain BMI thresholds and weight‑related health conditions) and for whom a GLP‑1‑only medicine is appropriate.
Adults who meet GLP‑1 eligibility criteria and where a clinician feels a dual‑hormone medicine is suitable, particularly when additional metabolic support is needed.
Typical weight‑loss seen in trials
Many people achieved around 15–20% body‑weight reduction when Weight loss treatment was combined with diet and activity changes.
Many people achieved around 15–23% body‑weight reduction at higher doses when GLP‑1 was combined with diet and activity changes.
Weight loss treatment has been studied in multi‑country trials lasting up to two years, with average weight reductions of around 10–17% when combined with lifestyle changes; real‑world studies report similar patterns over six months. ¹ ²
